Cardinal Capital Management LLC /Ct / LGND
Cardinal Capital Management LLC /Ct’s Ligand Pharmaceuticals Inc Position
Does Cardinal Capital Management LLC /Ct own Ligand Pharmaceuticals Inc (LGND)? Not currently — the last reported position was 133.7K shares worth $11M in Q2 2024; the fund’s latest 13F (Q3 2024) no longer reports it.
Position Value
$11M
Q2 2024
Shares
133.7K
% of Portfolio
+3.08%
Quarters Held
17
position exited
Position History LGND
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2024 | 133.7K | $11M | +3.08% |
| Q1 2024 | 559.2K | $41M | +2.05% |
| Q4 2023 | 221.9K | $16M | +0.73% |
| Q3 2023 | 206.4K | $12M | +0.53% |
| Q2 2023 | 212.8K | $15M | +0.58% |
| Q1 2023 | 202.0K | $15M | +0.53% |
| Q4 2021 | 162.6K | $25M | +0.59% |
| Q3 2021 | 209.7K | $29M | +0.70% |
| Q4 2020 | 1.09M | $108M | +3.16% |
| Q3 2020 | 941.3K | $90M | +3.75% |
| Q2 2020 | 868.4K | $97M | +4.06% |
| Q1 2020 | 982.0K | $71M | +3.51% |
| Q4 2019 | 920.0K | $96M | +2.93% |
| Q3 2019 | 893.4K | $89M | +2.94% |
| Q2 2019 | 896.6K | $102M | +3.34% |
| Q1 2019 | 882.5K | $111M | +3.69% |
| Q4 2018 | 506.5K | $69M | +2.53% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cardinal Capital Management LLC /Ct’s full portfolio or all institutional holders of LGND.